Aigen Investment Management, LP Reata Pharmaceuticals Inc Transaction History

Aigen Investment Management, LP

  • $487 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 10, 2020
SELL
$126.3 - $176.56 $701,596 - $980,790
-5,555 Closed
0 $0
Q1 2020

May 08, 2020
BUY
$124.16 - $247.74 $106,529 - $212,560
858 Added 18.27%
5,555 $802,000
Q4 2019

Feb 04, 2020
BUY
$74.57 - $217.92 $350,255 - $1.02 Million
4,697 New
4,697 $960,000

Others Institutions Holding RETA

# of Institutions
5
Shares Held
62.7K
Call Options Held
0
Put Options Held
0
View Full List

About REATA PHARMACEUTICALS INC

RETA Quotes by TradingView
  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Aigen Investment Management, LP Portfolio

Follow Aigen Investment Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Aigen Investment Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email